Caris Life Sciences (CAI) Invested Capital (2024 - 2026)

Caris Life Sciences' Invested Capital history runs 3 years deep, the most recent figure standing at $974.6 million for Q1 2026.

• In Q1 2026, Invested Capital rose 137.49% year-over-year to $974.6 million; the TTM figure through Mar 2026 stood at $974.6 million (up 137.49% YoY), while the FY2025 annual figure was $955.8 million, up 144.96% from the prior year.
• Invested Capital was $974.6 million for Q1 2026 at Caris Life Sciences, up from $955.8 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $974.6 million in Q1 2026 to a low of -$2.6 billion in Q1 2025.
• Historically, Invested Capital has averaged -$739.5 million across 3 years, with a median of -$649.7 million in 2024.
• Biggest YoY gain for Invested Capital was 144.96% in 2025; the steepest drop was 134.98% in 2025.
• A 3-year view of Invested Capital shows it stood at -$2.1 billion in 2024, then soared by 144.96% to $955.8 million in 2025, then advanced by 1.97% to $974.6 million in 2026.
• The last three Invested Capital figures came in at $974.6 million (Q1 2026), $955.8 million (Q4 2025), and $854.2 million (Q3 2025), per Business Quant data.